Significant Investor Interest
The pharmaceuticals and healthcare industries are increasingly profitable and are showing significant potential for investment and development in the countries of South East Europe. In addition to being lucrative places to sell medications and services, these countries are now being fully integrated into investment strategies for R&D hubs and manufacturing sites and are playing a vital role in the sustainable growth of the global industry. Because the pharmaceuticals and healthcare sectors in the region remain largely underdeveloped, regional governments are laying the ground for extensive reforms in legislation, privatization, consolidation and modernization of existing infrastructure and capacities, which has opened the region to significant investor interest. Our dedicated team of pharmaceuticals and healthcare experts bring together legal experience and industry insight to provide clients with unparalleled legal advisory and comprehensive analysis of any situation.
Understanding the Challenges
SELA acts for many of the top global pharmaceutical and healthcare companies operating in the region. Clients appreciate our knowledge and understanding of the key issues challenging the sector and our broad insight on trends and developments. We understand the regulatory environment and strategic goals of our client base, which enables us to provide them with the best legal support available in our markets. Our experts draw on their expertise in mergers and acquisitions, joint ventures, finance, regulatory, tax, competition, employment, restructuring technology and dispute resolution to provide premier legal service on both cross-border and domestic matters. In addition to day to day legal advisory, we advise on regulatory requirements, pricing, licensing, clinical trials, public procurement, marketing authorizations, Greenfield investments and commercial production and distribution contracts. Whatever you need, our experts are there to help.
- Longstanding expertise and integrated regional team of regulatory experts
- Niche expertise and a proven track record
- Comprehensive expertise and an in-depth understanding of the key issues affecting the sector